Dr. Yin feng, who graduated from Peking University in 2014 with a major in cell biology, has conducted in-depth research in the field of cancer and tumor stem cell epigenetics.From 2014 to 2015, he worked as a postdoctoral fellow at nanyang technological university in Singapore, where he studied the delivery system of cancer-targeted nanomaterials, and designed and developed a nano-silicon fluorescent probe targeting pancreatic cancer and a pancreatic cancer treatment complex using gold nanorods as gene/anticancer drug dual carrier.From 2016 to 2017, I worked as a postdoctoral fellow in professor li zigang's research group of shenzhen graduate school of Peking University, engaged in biomedical research on stable peptides and research on peptide delivery system. At the end of 2017, I served as an associate researcher, and designed and developed a series of stable peptide inhibitors with anti-cancer activity.In the past five years, I have applied for 7 patents (1 authorization) and published more than 40 articles in international academic journals (25 articles by the first author and corresponding author).They have been published in internationally renowned academic journals such as Cancer Research, Nano Letter, Material Horizons, Chemical Science, Coordination Chemistry Reviews, Theranostics, Advance Materials, Cell Reports, Chemistry Communication, etc.
- About UsBrief IntroductionOpening Remarks for 2020Organization and Structure
- Research & DevelopmentFieldsGroupsSkills&Platforms
- LaboratoryChemical SynthesisPeptide Drug Development CenterHerb & Natural Plant ExtractPreparation & FormulationQuality Analysis Center
- News and EventsAcademic SpotlightsIndustry and BusinessConferences Agenda